Cresco Labs Inc. (CRLBF) Gains from Sales and Divestitures (2022 - 2025)

Cresco Labs (CRLBF) has reported Gains from Sales and Divestitures for 4 consecutive years, with $169000.0 the latest figure, recorded in Q1 2025.

• For the quarter ending Q1 2025, Gains from Sales and Divestitures rose 253.64% year-over-year to $169000.0; the trailing twelve-month figure through Mar 2025 stood at $154000.0 (changed N/A YoY), and the FY2024 full-year result was $683000.0, up 5353.85% from the prior year.
• Gains from Sales and Divestitures improved to $169000.0 in Q1 2025 per CRLBF's latest filing, from -$110000.0 in the prior quarter.
• Across five years, Gains from Sales and Divestitures topped out at $169000.0 in Q1 2025 and bottomed at -$110000.0 in Q1 2024.
• Historically, Gains from Sales and Divestitures has averaged $38500.0 across 4 years, with a median of $47500.0 in 2022.
• The widest YoY moves for Gains from Sales and Divestitures: up 253.64% in 2025, down 253.64% in 2025.
• Over 4 years, Gains from Sales and Divestitures stood at -$55000.0 in 2022, then jumped by 372.73% to $150000.0 in 2023, then tumbled by 173.33% to -$110000.0 in 2024, then surged by 253.64% to $169000.0 in 2025.
• According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $169000.0, -$110000.0, and $150000.0 for Q1 2025, Q1 2024, and Q4 2023 respectively.